Dare Bioscience/$DARE
1D1W1MYTD1Y5YMAX
Capital at risk
About Dare Bioscience
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
- Ticker
- $DARE
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 23
- Headquarters
- San Diego, United States
- Website
- darebioscience.com
Dare Bioscience Metrics
BasicAdvanced
$11M
-
-$0.78
1.06
-
Price and volume
Market cap
$11M
Beta
1.06
52-week high
$3.78
52-week low
$0.69
Average daily volume
820K
Financial strength
Current ratio
0.986
Quick ratio
0.749
Long term debt to equity
-1,072.592
Total debt to equity
-1,207.575
Profitability
EBITDA (TTM)
-8.979
Gross margin (TTM)
243.91%
Net profit margin (TTM)
-804.37%
Operating margin (TTM)
-813.41%
Revenue per employee (TTM)
$60,000
Management effectiveness
Return on assets (TTM)
-39.29%
Return on equity (TTM)
165.30%
Valuation
Price to revenue (TTM)
7.373
Price to book
-19.28
Price to tangible book (TTM)
-19.28
Price to free cash flow (TTM)
-0.857
Free cash flow yield (TTM)
-116.73%
Free cash flow per share (TTM)
-0.832
Growth
Revenue change (TTM)
-7,816.73%
Earnings per share change (TTM)
-63.72%
3-year earnings per share growth (CAGR)
-48.11%
What the Analysts think about Dare Bioscience
Analyst ratings (Buy, Hold, Sell) for Dare Bioscience stock.
Analyst projections of the future price of Dare Bioscience stock.
Dare Bioscience Financial Performance
Revenues and expenses
Dare Bioscience Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.